Koch Kevin
- SEC CIK
- 0001185829
In the past year, 1 open-market sale filing worth $785.0K and no purchases.
Current role at each company
- EWTX Edgewise Therapeutics, Inc.President and CEOas of Aug 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $785.0K
- 1 filing
- Net
- −$785.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Koch Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 (view filing)4:52 PM ET | Aug 12 | 2 days | Koch KevinPresident and CEO | SSale | −18.0K | $43.68 | −$785.0K | −25.5%52.5K after | 3 lots |
| Aug 14, 2025 (view filing) | Aug 12 | 2 days | Koch KevinPresident and CEO | SSale | −7.97K | $13.39 | −$106.7K | −20.7%30.6K after | |
| May 7, 2025 (view filing) | May 2 | 5 daysLate | Koch KevinPresident and CEO | SSale | −4.28K | $16.45 | −$70.3K | −17.2%20.6K after | |
| Mar 11, 2025 (view filing)4:32 PM ET | Mar 7 | 4 days | Koch KevinPresident and CEO | SSale | −100 | $30.00 | −$3.00K | −0.7%14.5K after | 10b5-1 |
| Feb 7, 2025 (view filing)4:38 PM ET | Feb 5-6 | 2 days | Koch KevinPresident and CEO | SSale | −9.54K | $30.13 | −$287.3K | −39.7%14.5K after | 2 lots10b5-1 |
| May 3, 2024 (view filing) | May 2 | 1 day | Koch KevinPresident and CEO | SSale | −3.15K | $18.91 | −$59.6K | −17.9%14.5K after | |
| May 3, 2023 (view filing) | May 2 | 1 day | Koch KevinPresident and CEO | SSale | −3.20K | $8.90 | −$28.5K | −30.8%7.21K after |